Delhi HC: Alphabets ko trademark nahi kar sakte; Alkem ka 'A TO Z' Pharma plea reject.

LAWCOURT
Whalesbook Logo
AuthorIshaan Verma|Published at:
Delhi HC: Alphabets ko trademark nahi kar sakte; Alkem ka 'A TO Z' Pharma plea reject.
Overview

Delhi High Court ne kaha hai ki English alphabets ko trademark law ke through monopolize nahi kiya ja sakta. Isne Alkem Laboratories ki 'A TO Z' mark ko apne pharma products ke liye exclusively use karne ki request ko reject kar diya. Justice Tejas Karia ne mark ko descriptive paaya, jis se Alkem exclusivity claim nahi kar sakta. Is ruling se Prevego Healthcare apne 'Multivein AZ' brand ko use karna jari rakh sakta hai, kyunki significant differences hain aur Alkem ne pehle ke trademark issues ko disclose nahi kiya tha.

Descriptive Marks par Ruling

Delhi High Court ne ek important judgment diya hai ki English alphabets trademark exclusivity ke liye eligible nahi hain. Justice Tejas Karia ki bench ne Alkem Laboratories Limited ko 'A TO Z' mark ke liye interim protection dene se mana kar diya, yeh kehkar ki aise marks descriptive hain aur kisi ek entity dwara monopolize nahi kiye ja sakte. Court ne 'A' aur 'Z' letters par Alkem ke claim ko trademark law ke according unsupported paaya.

Competitor ki Branding Maintain

Yeh ruling tab aayi jab Alkem Laboratories ne Prevego Healthcare and Research Pvt Ltd par Prevego ke 'Multivein AZ' multivitamin product mein 'AZ' use karne ko lekar sue kiya. Alkem ka kehna tha ki Prevego ki branding uske 'A to Z' aur 'A to Z-NS' brands ko infringe karti hai, jinka use woh 1998 se kar raha hai. Lekin, court ne Prevego ke is defense se agree kiya ki 'A to Z' ek common phrase hai jo comprehensiveness batata hai aur exclusive trademark protection ke liye isme distinctiveness nahi hai. Prevego ne yeh bhi point out kiya ki Alkem ke paas Class 5 mein 'A to Z' ke liye registered word-mark nahi tha.

Non-Disclosure aur Infringement Claims

Alkem ki position aur kamzor hui jab court ne company ko Class 5 mein 'A TO Z' ke liye pehle withdraw kiye gaye, abandon kiye gaye ya oppose kiye gaye trademark applications ko disclose na karne ke liye criticize kiya. Is non-disclosure ne Alkem ko equitable relief paane se disqualify kar diya. Court ne Alkem ke copyright infringement claims ko bhi dismiss kar diya. Iske parinaam swaroop, Alkem ke favor mein pehle di gayi ex parte injunction ko vacate kar diya gaya, jisse Prevego 'Multivein AZ' ko market karna jari rakh sakta hai.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.